Patents by Inventor Rebecca Lynne Reynolds

Rebecca Lynne Reynolds has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TCF-1 nucleotide sequence variation
    Patent number: 6656691
    Abstract: Methods and reagents for determining sequence variants present at the TCF-1 locus, which facilitates identifying individuals at risk for Th1 diseases, such as type 1 diabetes or multiple sclerosis, or Th2 diseases, such as allergic asthma or atopy.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: December 2, 2003
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Ann Bethea Begovich, Henry Anthony Erlich, Andrew Grupe, Janelle Annette Noble, Gary Allen Peltz, Rebecca Lynne Reynolds, Karen Myra Walker, Gabriele Zangenberg
  • TCF-1 nucleotide sequence variation
    Publication number: 20030203395
    Abstract: Methods and reagents for determining sequence variants present at the TCF-1 locus, which facilitates identifying individuals at risk for Th1 diseases, such as type 1 diabetes or multiple sclerosis, or Th2 diseases, such as allergic asthma or atopy.
    Type: Application
    Filed: June 4, 2003
    Publication date: October 30, 2003
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Ann Bethea Begovich, Henry Anthony Erlich, Andrew Grupe, Janelle Annette Noble, Gary Allen Peltz, Rebecca` Lynne Reynolds, Karen Myra Walker, Gabriele Zangenberg
  • TCF-1 nucleotide sequence variation
    Publication number: 20030054350
    Abstract: Methods and reagents for determining sequence variants present at the TCF-1 locus, which facilitates identifying individuals at risk for Th1 diseases, such as type 1 diabetes or multiple sclerosis, or Th2 diseases, such as allergic asthma or atopy.
    Type: Application
    Filed: July 12, 2001
    Publication date: March 20, 2003
    Inventors: Ann Bethea Begovich, Henry Anthony Erlich, Andrew Grupe, Janelle Annette Noble, Gary Allen Peltz, Rebecca Lynne Reynolds, Karen Myra Walker, Gabriele Zangenberg
  • Nucleotide sequence variation in the ABO glycosyltransferase gene
    Patent number: 5763184
    Abstract: Methods and reagents for determining an individual's genotype at the ABO locus with respect to newly discovered polymorphisms, which facilitates typing tissue for determinign individual identity and has application in the field of forensic science.
    Type: Grant
    Filed: December 11, 1996
    Date of Patent: June 9, 1998
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Rebecca Lynne Reynolds, Gabriele Annemarie Zangenberg
  • Methods and reagents for Glycophorin A typing
    Patent number: 5643724
    Abstract: Methods and reagents for determining an individual's genotype at the Glycophorin A locus with respect to a set of five alleles using sequence-specific oligonucleotide probes enable one to type samples from a variety of sources, including samples comprising RNA or cDNA templates, and can be applied to nucleic acids in which a target region spanning the polymorphism has been amplified. This typing facilitates typing tissue for determining individual identity and has application in the field of forensic science.
    Type: Grant
    Filed: June 6, 1994
    Date of Patent: July 1, 1997
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Nicola Jane Fildes, Rebecca Lynne Reynolds